REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)

NACompletedINTERVENTIONAL
Enrollment

684

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

November 30, 2011

Conditions
Heart Failure
Interventions
DEVICE

Cardiac Resynchronization Therapy (CRT) Device or Implantable Cardioverter Defibrillator (ICD) with CRT

All randomized patients will be implanted with a market-released Medtronic CRT or CRT/ICD device.

Trial Locations (65)

Unknown

Huntsville

Anchorage

Redwood City

San Diego

Atlantis

Jacksonville

Springfield

Indianapolis

Des Moines

Boston

Burlington

Ann Arbor

Saginaw

Coon Rapids

Tupelo

Lincoln

East Syracuse

Manhasset

Winston-Salem

Cincinnati

Columbus

Marion

Doylestown

Hershey

West Reading

Charleston

Germantown

Kingsport

Austin

Houston

Salt Lake City

Norfolk

Richmond

Madison

Sankt Pölten

Weiner Neustadt

Leuven

Kingston

Brno

Olomouc

Aalborg

Aarhus

Copenhagen

Odense

Lyon

Marseille

Montpellier

Nantes

Rennes

Bochum

Hamburg

Hanover

Budapest

Szeged

Dublin

Busto Arsizio

Florence

Milan

Rome

Kristiansand

Madrid

Valencia

Linköping

Stockholm

Blackpool

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT00271154 - REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) | Biotech Hunter | Biotech Hunter